People with advanced or recurrent endometrial carcinoma are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:

• Are a female at least 18 years of age
• Are histologically confirmed with Stage III or IV or recurrent EC or Carcinosarcoma
• Have radiographically evaluable disease, either measurable or non-measurable
• Are HBsAg positive or have known history of HBV infection

You may not participate in this study if you:

• Have uterine mesenchymal tumor
• Have received prior systemic anticancer therapy including investigational agents
• Have received a live or live-attenuated vaccine within 30 days
• Have a known additional malignancy within the past 3 years
• Have an active autoimmune disease
• Have a known history of HIV infection
• Have a diagnosis of immunodeficiency
• Have had an allogenic tissue/solid organ transplant
• Are pregnant, breastfeeding, or planning to become pregnant

Contact Information
Neha Kumarley, Study Coordinator
Phone: (212) 824-7659